We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-17.26%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.29B
AUM Growth
-$744M
Cap. Flow
+$126M
Cap. Flow %
3.81%
Top 10 Hldgs %
18.14%
Holding
1,378
New
105
Increased
487
Reduced
524
Closed
187

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$6.95M
2
NKE icon
Nike
NKE
+$5.91M
3
UNH icon
UnitedHealth
UNH
+$5.38M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$5.36M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Healthcare 13.38%
3 Financials 10.48%
4 Consumer Discretionary 8.32%
5 Communication Services 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGOL icon
926
abrdn Physical Gold Shares ETF
SGOL
$7.51B
$276K 0.01%
18,230
HIO
927
Western Asset High Income Opportunity Fund
HIO
$340M
$274K 0.01%
+65,000
New +$312K
OUSA icon
928
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$757M
$274K 0.01%
9,422
-775
-8% -$26.5K
BBN icon
929
BlackRock Taxable Municipal Bond Trust
BBN
$986M
$273K 0.01%
+12,516
New +$307K
SAP icon
930
SAP
SAP
$234B
$273K 0.01%
2,475
+55
+2% +$6.94K
TD icon
931
Toronto Dominion Bank
TD
$203B
$273K 0.01%
6,447
+1,109
+21% +$56.9K
XLB icon
932
State Street Materials Select Sector SPDR ETF
XLB
$8.62B
$272K 0.01%
12,074
-66,078
-85% -$1.81M
ARDC
933
Are Dynamic Credit Allocation Fund
ARDC
$298M
$270K 0.01%
25,000
+8,100
+48% +$116K
DINO icon
934
HF Sinclair
DINO
$15.5B
$268K 0.01%
10,956
+1,045
+11% +$39K
ETR icon
935
Entergy
ETR
$50.1B
$268K 0.01%
5,696
+2,290
+67% +$136K
HRTX icon
936
Heron Therapeutics
HRTX
$66M
$268K 0.01%
22,800
FCN icon
937
FTI Consulting
FCN
$4.16B
$267K 0.01%
2,233
-139
-6% -$16.4K
EVH icon
938
Evolent Health
EVH
$495M
$266K 0.01%
49,060
+5,000
+11% +$44.7K
JAZZ icon
939
Jazz Pharmaceuticals
JAZZ
$16.2B
$266K 0.01%
+2,667
New +$345K
ADPT icon
940
Adaptive Biotechnologies
ADPT
$3.97B
$265K 0.01%
9,556
-912
-9% -$25.4K
SFBS
941
ServisFirst Bancshares
SFBS
$4.93B
$264K 0.01%
+9,000
New +$315K
QRVO icon
942
Qorvo
QRVO
$8.54B
$263K 0.01%
3,265
-5
-0.2% -$500
CRL icon
943
Charles River Laboratories
CRL
$13.7B
$261K 0.01%
2,068
-1,062
-34% -$159K
MGF
944
Aberdeen Government Markets Income Fund
MGF
$92.6M
$261K 0.01%
57,595
-8,715
-13% -$39.7K
CPLG
945
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$261K 0.01%
66,567
CASY icon
946
Casey's General Stores
CASY
$30.9B
$260K 0.01%
1,962
+202
+11% +$32.7K
YORW icon
947
York Water
YORW
$525M
$260K 0.01%
5,973
ALLO icon
948
Allogene Therapeutics
ALLO
$728M
$259K 0.01%
13,300
+5,500
+71% +$131K
BNDX icon
949
Vanguard Total International Bond ETF
BNDX
$82.9B
$259K 0.01%
+4,596
New +$263K
LYB icon
950
LyondellBasell Industries
LYB
$20.3B
$259K 0.01%
5,215
+1,642
+46% +$121K

Similar funds

Oppenheimer & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Oppenheimer & Co held 1,378 positions worth $3.29B, down 18% from $4.04B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $126M of net new capital in Q1 2020, opening 105 new positions and adding to 487 existing holdings. Its largest new stake was Hasbro: 50,954 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Target, an estimated $6.95M trimmed.

  • Oppenheimer & Co's largest Q1 2020 buy was Hasbro: 50,954 shares worth $3.65M.
  • Oppenheimer & Co added most to Invesco QQQ Trust in Q1 2020, an estimated $24.5M increase.
  • Oppenheimer & Co's biggest Q1 2020 reduction was Target, cutting an estimated $6.95M.
  • Oppenheimer & Co fully exited Campbell Soup in Q1 2020, selling an estimated $3.76M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $3.29B portfolio in Q1 2020.
  • Oppenheimer & Co opened 105 new positions and closed 187 in Q1 2020.
  • Oppenheimer & Co's portfolio value fell 18% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.